LAUSR

Oncotarget (ONCOALVO): A custom NGS panel for therapeutic decision in solid tumors refractory to conventional therapy.

Sign Up to like & get
recommendations!
1 Published in 2019 at "Journal of Global Oncology"

DOI: 10.1200/jgo.2019.5.suppl.140

Abstract: 140 Background: Next-generation sequencing (NGS) of tumor biopsies of solid tumors using commercially available platforms has broadly entered routine clinical practice to test for predictive biomarkers for patients with no available further standard therapies, as… read more here.

Keywords: solid tumors; oncotarget oncoalvo; therapy; oncology ... See more keywords